Whitehawk Therapeutics, Inc. (WHWK) › Shareholders' EquityWhitehawk Therapeutics, Inc. (WHWK) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2007: $35.0K2008: $1.4K2009: -$18.6K2010: -$41.0K2011: -$68.2K2012: -$95.5K2013: -$124.2K2014: -$155.0K2015: -$66.55M2016: -$86.22M2017: $17.44M2018: $58.67M2019: -$9.09M2020: -$12.43M2021: $136.41M2022: $158.38M2023: $105.19M2024: $52.48M2025: $136.31M$136.31M2007Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$136.31M+159.7%2024$52.48M-50.1%2023$105.19M-33.6%2022$158.38M+16.1%2021$136.41M+1197.2%2020-$12.43M-36.7%2019-$9.09M-115.5%2018$58.67M+236.5%2017$17.44M+120.2%2016-$86.22M-29.5%2015-$66.55M-42827.2%2014-$155.0K-24.8%2013-$124.2K-30.0%2012-$95.5K-40.1%2011-$68.2K-66.3%2010-$41.0K-120.4%2009-$18.6K-1428.3%2008$1.4K-96.0%2007$35.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share